06 Nov The epigenetic silencing of the PI3K-Akt pathway impacts immune checkpoint blockade in NSCLC

Posted at 13:33h in INMUNOTHERAPY by

ID: 03234

Authors: Gallardo-Gómez, María (1); Termenón-Rivas, Uxía (1); Lázaro, Martín E. (1); Pino-González, Manuel (1); Alonso-Álvarez, Irene (1); García-Benito, Carme (1); Juaneda-Magdalena, Laura (1); Rodríguez-Casanova, Aitor (2); Díaz-Lagares, Ángel (2); Martínez-Fernández, Mónica (1)

Topic: INMUNOTHERAPY